Public Citizen's health and safety work protects consumers by advocating for safer, more effective drugs, medical devices and other products; equitable health care services and more physician accountability; safer cars and trucks; and improvements in worker safety. View the Health Research Group's work listed chronologically.
The National Institutes of Health (NIH) exposed 1,316 premature infants to increased risk of blindness and death as part of a clinical trial - known as the SUPPORT study - without parents of the babies being informed of the risks to their babies.
Dec 18 - Presentation on Pharmacy Compounding before the Food and Drug Law Institute Enforcement, Litigation, and Compliance Conference
Dec 17 - Letter to FDA Commissioner Margaret Hamburg Criticizing Agency Messages Endorsing Compounded Drugs Made by Outsourcing Facilities
Dec 16 - Letter to the FDA Calling for Public Disclosure of Meta-Analyses Performed by the Agency
Dec 12 - Testimony to FDA Endocrinologic and Metabolic Drugs Advisory Committee on Dapagliflozin for Treatment of Type 2 Diabetes Mellitus
Dec 2 - Letter to the FDA Opposing Approval of the CardioMEMS Champion Heart Failure Monitoring System
Nov 18 - Commentary in The New York Times “Room for Debate” Series on Trying Newly Approved Medications
Please wait while my tweets load
If you can't wait - click here
Retailer that fined couple $3,500 for negative review hit with lawsuit - U.S. News
Court rejects Obama admin executive privilege arguments - The Washington Free Beacon
Side effects may include death: The story of the biggest advance in birth control since the pill - Huffington Post
Global Trade Watch
Health Research Group
Copyright © 2013 Public Citizen. All rights reserved. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation.
Learn More about the distinction between these two components of Public Citizen.
Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.
Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.
You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.